Orgenesis Inc ORGS:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
1.42quote price arrow up+0.04 (+2.90%)
Volume
21,363
52 week range
1.31 - 5.20
Loading...
  • Open1.38
  • Day High1.44
  • Day Low1.38
  • Prev Close1.38
  • 52 Week High5.20
  • 52 Week High Date11/04/21
  • 52 Week Low1.31
  • 52 Week Low Date09/29/22

Key Stats

  • Market Cap36.28M
  • Shares Out25.55M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.80
  • YTD % Change-50.69

KEY STATS

  • Open1.38
  • Day High1.44
  • Day Low1.38
  • Prev Close1.38
  • 52 Week High5.20
  • 52 Week High Date11/04/21
  • 52 Week Low1.31
  • 52 Week Low Date09/29/22
  • Market Cap36.28M
  • Shares Out25.55M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.80
  • YTD % Change-50.69

RATIOS/PROFITABILITY

  • EPS (TTM)-1.01
  • P/E (TTM)-1.41
  • Fwd P/E (NTM)14.20
  • EBITDA (TTM)-20.609M
  • ROE (TTM)-59.22%
  • Revenue (TTM)29.98M
  • Gross Margin (TTM)22.65%
  • Net Margin (TTM)-82.25%
  • Debt To Equity (MRQ)61.59%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Orgenesis Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Orgenesis Inc. is a global biotech company that is operating to unlock the potential of cell and gene therapies (CGTs). The Company is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). It has developed a Point of Care Platform (POCare Platform) comprised of...
Vered Caplan
Chairperson of the Board of Directors, Chief Executive Officer
Neil Reithinger CPA
Chief Financial Officer, Treasurer, Secretary
Address
20271 Goldenrod Lane
Germantown, MD
20876
United States

Top Peers

SYMBOLLASTCHG%CHG
ANGN
Angion Biomedica Corp
0.92+0.0197+2.19%
MTEM
Molecular Templates Inc
0.7497+0.0276+3.82%
CDTX
Cidara Therapeutics Inc
0.628-0.0221-3.3995%
SYRS
Syros Pharmaceuticals Inc
6.44+0.60+10.27%
SURF
Surface Oncology Inc
1.04-0.03-2.80%